APA

Jiménez-Ramírez F. J., Castro L. M., Ortiz C., Concepción J., Renta J. Y., Morales-Borges R. H., Miranda-Massari J. R. & Duconge J. (20171108). Role of treatment-modifying MTHFR677C>T and 1298A>C polymorphisms in metformin-treated Puerto Rican patients with type-2 diabetes mellitus and peripheral neuropathy. : Drug metabolism and personalized therapy.

Chicago

Jiménez-Ramírez Francisco J, Castro Liza M, Ortiz Clarymar, Concepción Jennifer, Renta Jessicca Y, Morales-Borges Raúl H, Miranda-Massari Jorge R and Duconge Jorge. 20171108. Role of treatment-modifying MTHFR677C>T and 1298A>C polymorphisms in metformin-treated Puerto Rican patients with type-2 diabetes mellitus and peripheral neuropathy. : Drug metabolism and personalized therapy.

Harvard

Jiménez-Ramírez F. J., Castro L. M., Ortiz C., Concepción J., Renta J. Y., Morales-Borges R. H., Miranda-Massari J. R. and Duconge J. (20171108). Role of treatment-modifying MTHFR677C>T and 1298A>C polymorphisms in metformin-treated Puerto Rican patients with type-2 diabetes mellitus and peripheral neuropathy. : Drug metabolism and personalized therapy.

MLA

Jiménez-Ramírez Francisco J, Castro Liza M, Ortiz Clarymar, Concepción Jennifer, Renta Jessicca Y, Morales-Borges Raúl H, Miranda-Massari Jorge R and Duconge Jorge. Role of treatment-modifying MTHFR677C>T and 1298A>C polymorphisms in metformin-treated Puerto Rican patients with type-2 diabetes mellitus and peripheral neuropathy. : Drug metabolism and personalized therapy. 20171108.